Publications - Resham Bhattacharya, Ph.D.

Back to research profile

1. Arvizo RR, Moyano DF, Saha S, Thompson MA, Bhattacharya R, Rotello VM, Prakash YS, Mukherjee P. Probing Novel Roles of the Mitochondrial Uniporter in Ovarian Cancer Cells Using Nanoparticles. J Biol Chem. 2013 Apr 24. [Epub ahead of print]
   View PubMed
2. Arvizo RR, Saha S, Wang E, Robertson JD, Bhattacharya R, Mukherjee P. Inhibition of tumor growth and metastasis by a self-therapeutic nanoparticle. Proc Natl Acad Sci U S A. 2013 Apr 23; 110(17):6700-5. Epub 2013 Apr 08.
   View PubMed
3. Sinha S, Pal K, Elkhanany A, Dutta S, Cao Y, Mondal G, Iyer S, Somasundaram V, Couch FJ, Shridhar V, Bhattacharya R, Mukhopadhyay D, Srinivas P. Plumbagin inhibits tumorigenesis and angiogenesis of ovarian cancer cells in vivo. Int J Cancer. 2013 Mar 1; 132(5):1201-12. Epub 2012 Jul 27.
   View PubMed
4. Kudgus RA, Szabolcs A, Khan JA, Walden CA, Reid JM, Robertson JD, Bhattacharya R, Mukherjee P. Inhibiting the growth of pancreatic adenocarcinoma in vitro and in vivo through targeted treatment with designer gold nanotherapeutics. PLoS One. 2013; 8(3):e57522. Epub 2013 Mar 06.
   View PubMed
5. Hoeppner LH, Phoenix KN, Clark KJ, Bhattacharya R, Gong X, Sciuto TE, Vohra P, Suresh S, Bhattacharya S, Dvorak AM, Ekker SC, Dvorak HF, Claffey KP, Mukhopadhyay D. Revealing the role of phospholipase Cbeta3 in the regulation of VEGF-induced vascular permeability. Blood. 2012 Sep 13; 120(11):2167-73. Epub 2012 Jun 06.
   View PubMed
6. Bhattacharya R, Wang E, Dutta SK, Vohra PK, E G, Prakash YS, Mukhopadhyay D. NHERF-2 maintains endothelial homeostasis. Blood. 2012 May 17; 119(20):4798-806. Epub 2012 Feb 17.
   View PubMed
7. Arvizo RR, Bhattacharyya S, Kudgus RA, Giri K, Bhattacharya R, Mukherjee P. Intrinsic therapeutic applications of noble metal nanoparticles: past, present and future. Chem Soc Rev. 2012 Apr 7; 41(7):2943-70. Epub 2012 Mar 05.
   View PubMed
8. Bhattacharyya S, Singh RD, Pagano R, Robertson JD, Bhattacharya R, Mukherjee P. Switching the targeting pathways of a therapeutic antibody by nanodesign. Angew Chem Int Ed Engl. 2012 Feb 13; 51(7):1563-7. Epub 2011 Dec 01.
   View PubMed
9. Arvizo RR, Giri K, Moyano D, Miranda OR, Madden B, McCormick DJ, Bhattacharya R, Rotello VM, Kocher JP, Mukherjee P. Identifying new therapeutic targets via modulation of protein corona formation by engineered nanoparticles. PLoS One. 2012; 7(3):e33650. Epub 2012 Mar 19.
   View PubMed
10. Kudgus RA, Bhattacharya R, Mukherjee P. Cancer nanotechnology: emerging role of gold nanoconjugates. Anticancer Agents Med Chem. 2011 Dec; 11(10):965-73.
    View PubMed
11. Bhattacharyya S, Khan JA, Curran GL, Robertson JD, Bhattacharya R, Mukherjee P. Efficient delivery of gold nanoparticles by dual receptor targeting. Adv Mater. 2011 Nov 16; 23(43):5034-8. Epub 2011 Oct 04.
    View PubMed
12. Arvizo RR, Rana S, Miranda OR, Bhattacharya R, Rotello VM, Mukherjee P. Mechanism of anti-angiogenic property of gold nanoparticles: role of nanoparticle size and surface charge. Nanomedicine. 2011 Oct; 7(5):580-7. Epub 2011 Feb 17.
    View PubMed
13. Bhattacharyya S, Gonzalez M, Robertson JD, Bhattacharya R, Mukherjee P. A simple synthesis of a targeted drug delivery system with enhanced cytotoxicity. Chem Commun (Camb). 2011 Aug 14; 47(30):8530-2. Epub 2011 Jun 30.
    View PubMed
14. Bhattacharyya S, Kudgus RA, Bhattacharya R, Mukherjee P. Inorganic nanoparticles in cancer therapy. Pharm Res. 2011 Feb; 28(2):237-59. Epub 2010 Nov 23.
    View PubMed
15. Manickam V, Tiwari A, Jung JJ, Bhattacharya R, Goel A, Mukhopadhyay D, Choudhury A. Regulation of vascular endothelial growth factor receptor 2 trafficking and angiogenesis by Golgi localized t-SNARE syntaxin 6. Blood. 2011 Jan 27; 117(4):1425-35. Epub 2010 Nov 09.
    View PubMed
16. Wang E, Bhattacharyya S, Szabolcs A, Rodriguez-Aguayo C, Jennings NB, Lopez-Berestein G, Mukherjee P, Sood AK, Bhattacharya R. Enhancing chemotherapy response with Bmi-1 silencing in ovarian cancer. PLoS One. 2011; 6(3):e17918. Epub 2011 Mar 21.
    View PubMed
17. Khan JA, Kudgus RA, Szabolcs A, Dutta S, Wang E, Cao S, Curran GL, Shah V, Curley S, Mukhopadhyay D, Robertson JD, Bhattacharya R, Mukherjee P. Designing nanoconjugates to effectively target pancreatic cancer cells in vitro and in vivo. PLoS One. 2011; 6(6):e20347. Epub 2011 Jun 27.
    View PubMed
18. Arvizo RR, Miranda OR, Moyano DF, Walden CA, Giri K, Bhattacharya R, Robertson JD, Rotello VM, Reid JM, Mukherjee P. Modulating pharmacokinetics, tumor uptake and biodistribution by engineered nanoparticles. PLoS One. 2011; 6(9):e24374. Epub 2011 Sep 13.
    View PubMed
19. Mukherjee P, Katarya A, McMaster N, Gonzalez MA, Bhattacharya R. Synthesis of silver nanocubes by photoreduction of silver salts in the presence of proteins. International Journal of Green Nanotechnology: Biomedicine. 2011; 3(2):134-9.
20. Bhattacharyya S, Bhattacharya R, Curley S, McNiven MA, Mukherjee P. Nanoconjugation modulates the trafficking and mechanism of antibody induced receptor endocytosis. Proc Natl Acad Sci U S A. 2010 Aug 17; 107(33):14541-6. Epub 2010 Aug 02.
    View PubMed
21. Arvizo RR, Miranda OR, Thompson MA, Pabelick CM, Bhattacharya R, Robertson JD, Rotello VM, Prakash YS, Mukherjee P. Effect of nanoparticle surface charge at the plasma membrane and beyond. Nano Lett. 2010 Jul 14; 10(7):2543-8.
    View PubMed
22. Arvizo R, Bhattacharya R, Mukherjee P. Gold nanoparticles: opportunities and challenges in nanomedicine. Expert Opin Drug Deliv. 2010 Jun; 7(6):753-63.
    View PubMed
23. Patra CR, Bhattacharya R, Mukhopadhyay D, Mukherjee P. Fabrication of gold nanoparticles for targeted therapy in pancreatic cancer. Adv Drug Deliv Rev. 2010 Mar 8; 62(3):346-61. Epub 2009 Nov 13.
    View PubMed
24. Bhattacharya R, Nicoloso M, Arvizo R, Wang E, Cortez A, Rossi S, Calin GA, Mukherjee P. MiR-15a and MiR-16 control Bmi-1 expression in ovarian cancer. Cancer Res. 2009 Dec 1; 69(23):9090-5. Epub 2009 Nov 10.
    View PubMed
25. Bhattacharya R, Kwon J, Ali B, Wang E, Patra S, Shridhar V, Mukherjee P. Role of hedgehog signaling in ovarian cancer. Clin Cancer Res. 2008 Dec 1; 14(23):7659-66.
    View PubMed
26. Bhattacharya R, Sinha S, Yang SP, Patra C, Dutta S, Wang E, Mukhopadhyay D. The neurotransmitter dopamine modulates vascular permeability in the endothelium. J Mol Signal. 2008; 3:14. Epub 2008 Jul 28.
    View PubMed
27. Bhattacharya R, Kwon J, Wang E, Mukherjee P, Mukhopadhyay D. Src homology 2 (SH2) domain containing protein tyrosine phosphatase-1 (SHP-1) dephosphorylates VEGF Receptor-2 and attenuates endothelial DNA synthesis, but not migration*. J Mol Signal. 2008; 3:8. Epub 2008 Mar 31.
    View PubMed
28. R. Bhattacharya, Chittaranjan Patra, Priyabrata Mukherjee, Debabrata Mukhopadhyay. Assembly of gold nanoparticles in a rod like fashion using biomolecular template ( (3) February, , 319-446). February, 2006; Adv. Func. Materials. Vol:16.
29. R. Resham Bhattacharya, Mark Bolander, Debabrata Mukhopadhyay, Gobinda Sarkar, Priyabrata Mukherjee. microarray analysis (J Biomed Nanotech Vol1 (4) Dec , 224-228). Dec 2005; Gold nanoparticles do not affect global transcriptional program of human umbilical vein endothelial cells:A DNA.
30. Bhattacharya R, Kang-Decker N, Hughes DA, Mukherjee P, Shah V, McNiven MA, Mukhopadhyay D. Regulatory role of dynamin-2 in VEGFR-2/KDR-mediated endothelial signaling. FASEB J. 2005 Oct; 19(12):1692-4. Epub 2005 Jul 27.
    View PubMed
31. R. Bhattacharya, Sucharita SenBanerjee, Zhiyong Lin, Samy Mir, Anne Hamik, Ping Wang, D. Mukhopadhyay and Mukesh K Jain Inhibition of VPF/VEGF-mediated angiogenesis by the Kruppel-like factor KLF2 (J Biol Chem 280 (). 2005 Aug 12; 32):28848-51.
32. Mukherjee P, Bhattacharya R, Wang P, Wang L, Basu S, Nagy J, Atala A, Mukhopadhyay D, Soker S. Anti Angiogenic Property of Gold Nanoparticles. (Clinical Cancer Research 11 (9). 2005; 3530-3534).
33. Mukherjee P, Bhattacharya R, Mukhopadhyay D. Gold nanoparticles bearing functional anti-cancer drug and anti-angiogenic agent: A “ 2 in 1” system with potential application in cancer therapeutics. J Biomed Nanotech. 2005; 2:224.
34. Bhattacharya R, Mukherjee P, Xiong Z, Atala A, Soker S, Mukhopadhyay D. Gold nanoparticles inhibit VEGF165-induced proliferation of HUVEC cells. Nano lett. 2004 Dec; 4(12):2479-81.
35. Zeng H, Bhattacharya R, Mukhopadhyay D. Complexity in VPF/VEGF receptors signaling. (Mol Cell Biochem , 264 (1-2),. 2004; 51-61).
36. Datta K, Li J, Bhattacharya R, Gasparian L, Wang E, Mukhopadhyay D. Role of PKC zeta in regulation of HIF 2 alpha by promoting its association with p300 in renal cancer. (Cancer Research 64, Jan ,. Jan 2003; 456-462).
37. Bhattacharya R, Beck DJ. The role of the RecFOR, RecBCD pathways and the polB gene in survival and induction of the SOS response in E. coli (DNA Repair ( , 1 (11), 955-966). 2002, 1; Amst).